ME1 Share Price Performance
AU$0
0.00 (0.00%)
Price AU$0
Share Pricen/a
Melodiol Global Health Limited (ASX:ME1) Stock's 40% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 01
Melodiol Global Health Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ME1 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Melodiol Global Health Limited Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
- -0.032
- 4.32%
- -187.73%
- -232.0%
About ME1
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
